{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:36:02Z","timestamp":1759178162760,"version":"3.40.4"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1097\/mcg.0000000000000076","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T09:31:53Z","timestamp":1390469513000},"page":"e31-e40","source":"Crossref","is-referenced-by-count":20,"title":["Distinct Features in Natural History and Outcomes of Acute Hepatitis C"],"prefix":"10.1097","volume":"49","author":[{"given":"Chalermrat","family":"Bunchorntavakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Valiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick A.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Aytaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyong-Mi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210201","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2009.09.019","article-title":". Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.","volume":"138","author":"Dore","year":"2010","journal-title":"Gastroenterology"},{"key":"R2-2-20210201","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1572-0241.2008.01825.x","article-title":"Acute hepatitis C: a systematic review.","volume":"103","author":"Kamal","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R3-2-20210201","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2036.2010.04549.x","article-title":". The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes.","volume":"33","author":"Loomba","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R4-2-20210201","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MEG.0b013e328330a8e8","article-title":". Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort.","volume":"22","author":"Morin","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R5-2-20210201","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1086\/507640","article-title":". Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy.","volume":"43","author":"Santantonio","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R6-2-20210201","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1086\/522608","article-title":". Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.","volume":"196","author":"Wang","year":"2007","journal-title":"J Infect Dis"},{"key":"R7-2-20210201","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jmv.23485","article-title":". Risk factors for and incidence of acute hepatitis C after the achievement of blood supply safety in Italy: results from the national surveillance system.","volume":"85","author":"Spada","year":"2013","journal-title":"J Med Virol"},{"key":"R8-2-20210201","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","article-title":". Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.","volume":"125","author":"Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"R9-2-20210201","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":". Treatment of acute hepatitis C with interferon alfa-2b.","volume":"345","author":"Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"key":"R10-2-20210201","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/j.gastro.2006.01.034","article-title":". Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.","volume":"130","author":"Kamal","year":"2006","journal-title":"Gastroenterology"},{"key":"R11-2-20210201","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.21197","article-title":". Duration of peginterferon therapy in acute hepatitis C: a randomized trial.","volume":"43","author":"Kamal","year":"2006","journal-title":"Hepatology"},{"key":"R12-2-20210201","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/605561","article-title":". Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria.","volume":"49","author":"McGovern","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R13-2-20210201","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1537-2995.2003.00355.x","article-title":". Fluctuation of HCV viral load before seroconversion in a healthy volunteer blood donor.","volume":"43","author":"Fang","year":"2003","journal-title":"Transfusion"},{"key":"R14-2-20210201","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2012.07.007","article-title":"Case definitions for acute hepatitis C virus infection: a systematic review.","volume":"57","author":"Hajarizadeh","year":"2012","journal-title":"J Hepatol"},{"key":"R15-2-20210201","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/infdis\/jit270","article-title":". Occupational exposure to hepatitis C virus: early T-cell responses in the absence of seroconversion in a longitudinal cohort study.","volume":"208","author":"Heller","year":"2013","journal-title":"J Infect Dis"},{"key":"R16-2-20210201","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/j.gastro.2006.11.044","article-title":". Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.","volume":"132","author":"Kaplan","year":"2007","journal-title":"Gastroenterology"},{"key":"R17-2-20210201","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jhep.2008.01.030","article-title":". Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis.","volume":"48","author":"Kaplan","year":"2008","journal-title":"J Hepatol"},{"key":"R18-2-20210201","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","article-title":". Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.","volume":"134","author":"Nakamoto","year":"2008","journal-title":"Gastroenterology"},{"key":"R19-2-20210201","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2005-864778","article-title":"Acute hepatitis C: a multifaceted disease.","volume":"25","author":"Heller","year":"2005","journal-title":"Semin Liver Dis"},{"key":"R20-2-20210201","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/hep.25575","article-title":". Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.","volume":"55","author":"Liu","year":"2012","journal-title":"Hepatology"},{"key":"R21-2-20210201","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2010.07.005","article-title":". A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.","volume":"139","author":"Tillmann","year":"2010","journal-title":"Gastroenterology"},{"key":"R22-2-20210201","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":". Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.","volume":"43","author":"Wiegand","year":"2006","journal-title":"Hepatology"},{"key":"R23-2-20210201","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(13)62121-2","article-title":". Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.","volume":"383","author":"Lawitz","year":"2014","journal-title":"Lancet"},{"key":"R24-2-20210201","first-page":"227A","article-title":". Telaprevir in the treatment of acute HCV infection in HIV-infected men: SVR 12 results.","volume":"55","author":"Fierer","year":"2013","journal-title":"Hepatology"},{"key":"R26-2-20210201","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1086\/504327","article-title":". Acute hepatitis C virus infection in incarcerated injection drug users.","volume":"42","author":"McGovern","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R28-2-20210201","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/j.1440-1746.2007.05032.x","article-title":". Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users.","volume":"22","author":"Grebely","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"R29-2-20210201","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1111\/j.1572-0241.2000.02337.x","article-title":"Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection.","volume":"95","author":"Liaw","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R30-2-20210201","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/jhep.2002.36129","article-title":". Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies.","volume":"36","author":"Larghi","year":"2002","journal-title":"Hepatology"},{"key":"R31-2-20210201","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2893.2008.01035.x","article-title":". Autoantibodies in chronic hepatitis C virus infection and their association with disease profile.","volume":"16","author":"Williams","year":"2009","journal-title":"J Viral Hepat"},{"key":"R32-2-20210201","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2893.1995.tb00026.x","article-title":". Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America.","volume":"2","author":"Reddy","year":"1995","journal-title":"J Viral Hepat"},{"key":"R33-2-20210201","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/gast.2003.50018","article-title":". Progression of fibrosis in chronic hepatitis C.","volume":"124","author":"Ghany","year":"2003","journal-title":"Gastroenterology"},{"key":"R34-2-20210201","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":". FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"R35-2-20210201","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":". Development of a simple noninvasive index to predict significant fibrosis in patients with HIVHCV coinfection.","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R36-2-20210201","first-page":"1","article-title":"Surveillance for acute viral hepatitisUnited States, 2007.","volume":"58","author":"Daniels","year":"2009","journal-title":"MMWR Surveill Summ"},{"key":"R37-2-20210201","first-page":"945","article-title":". Sexual transmission of hepatitis C virus among HIV-infected men who have sex with menNew York City, 2005-2010.","volume":"60","author":"Fierer","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R38-2-20210201","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-11-39","article-title":". Incidence of hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: a cohort study.","volume":"11","author":"Gamage","year":"2011","journal-title":"BMC Infect Dis"},{"key":"R39-2-20210201","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/sextrans-2012-050566","article-title":". Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review.","volume":"88","author":"Yaphe","year":"2012","journal-title":"Sex Transm Infect"},{"key":"R40-2-20210201","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/j.gastro.2009.02.006","article-title":". Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men.","volume":"136","author":"van de Laar","year":"2009","journal-title":"Gastroenterology"},{"key":"R41-2-20210201","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.24754","article-title":". Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection.","volume":"55","author":"Grebely","year":"2012","journal-title":"Hepatology"},{"key":"R43-2-20210201","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":". Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"R44-2-20210201","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1053\/j.gastro.2008.02.069","article-title":"Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors.","volume":"134","author":"Missiha","year":"2008","journal-title":"Gastroenterology"},{"key":"R45-2-20210201","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":". Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"key":"R47-2-20210201","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/cid\/cir854","article-title":". Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals.","volume":"54","author":"Vogel","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R48-2-20210201","first-page":"2S36","article-title":"The natural history of recurrent hepatitis C and what influences this.","volume":"14suppl","author":"Gane","year":"2008","journal-title":"Liver Transpl"},{"key":"R49-2-20210201","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2893.2005.00682.x","article-title":". Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 23, and this is not explained by more frequent dose reductions of interferon and ribavirin.","volume":"13","author":"Brau","year":"2006","journal-title":"J Viral Hepat"},{"key":"R50-2-20210201","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2174\/138161208784746824","article-title":". HCV and autoimmunity.","volume":"14","author":"Ferri","year":"2008","journal-title":"Curr Pharm Des"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0000000000000076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T16:51:31Z","timestamp":1746118291000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201504000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000000076","relation":{},"ISSN":["0192-0790"],"issn-type":[{"type":"print","value":"0192-0790"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}